Moderna to advance two vaccine candidates against Omicron variants

Reuters|
PrintFind an error? Report us
Moderna Inc said on Monday it was advancing two vaccine candidates for the fall, one designed against the BA.1 variant of Omicron and another against the BA.4 and BA.5 subvariants.
This has been done based on different market preferences for vaccines against Omicron subvariants, the company said.
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""